What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
There is no denying it. The holiday season is in full force and will continue through New Year's Day. One way you are most likely... Read more »
I've been reading some research on a guest speaker coming to Washington, DC, on March 1, 2010, for our JDRF capitol chapter research... Read more »
Non-Steroidal Anti-Inflammatory Drugs(NSAIDs) are the most prescribed medications in the world, but are also the most misunderstood... Read more »
The Anti-Inflammatory Diet has been popping up everywhere lately. It is especially interesting in the realm of diseases like IBD. The... Read more »
The foods you eat can make such a difference in your overall health and long-term well-being. Take, for instance, the anti-inflammatory... Read more »
It’s long been known that there is a link between chronic pain and depression, but a new study suggests there may be a connection between the drugs... Read more »
Drugmaker Nicox has submitted a new drug application to the U.S. Food and Drug Administration for its new anti-inflammatory medication Naproxcinod as... Read more »
This is a study to determine the effectiveness of the anti-inflammatory drug ODSH when used in conjunction with standard treatments for chronic... Read more »
Patients who regularly take a non-steroidal anti-inflammatory medication, such as a COX-2 inhibitor, may be prone to stomach ulcers. New research has... Read more »
Experts at the Mayo Clinic have compiled a list of medications and tips that may help prevent or delay the onset of Alzheimer's. Medications such as... Read more »